Russ­ian in­va­sion of Ukraine threat­ens hun­dreds of clin­i­cal tri­als

Day 2 of the Russ­ian in­va­sion has brought head­lines of a bat­tle for the na­tion’s cap­i­tal, signs that mil­lions of Ukraini­ans may be­come refugees and short­ages of food and med­i­cine that threat­ens every­one in the coun­try.

For biotech an­a­lysts, though, their job has cen­tered on the po­ten­tial dis­rup­tion around hun­dreds of on­go­ing drug tri­als and the po­ten­tial im­pli­ca­tions for the in­dus­try, as Ukraine is ripped apart by a bloody war and Rus­sia — which al­so hosts stud­ies — faces eco­nom­ic sanc­tions.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN